Clinical Pharmacology Tobacco Core Services and Rates
Rates Effective July 1, 2023 through June 30, 2024
| Method | Cancer Center* Rate | UCSF Recharge | External Non-industry | External Industry |
|---|---|---|---|---|
| Category A: LC-MS/MS. Straightforward Sample Prep and Data Analysis: ex. Cotinine/3HC, or Anabasine/Anatabine, or NNN/NNK | * | $119 | $159 | $179 |
| Category B: LC-MS/MS. Moderate Sample Prep/Data Analysis: ex. Bupropion and Bupropion Metabolites, or Caffeine and Caffeine Metabolites | * | $134 | $179 | $201 |
| Category C: LC-MS/MS. Complex Sample Prep/Data Analysis: such as: NNAL; or PAH Metabolites; or Mercapturic acid metabolites; or Total Nicotine Equivalents | * | $182 | $243 | $273 |
| Category E: GC-MS/MS, Triple Quadrupole MS: ex Low-Level Nicotine, or PAHs | * | $138 | $184 | $207 |
| Category F: GC: Nicotine/Cotinine | * | $79 | $106 | $119 |
| Category G: Creatinine | * | $47 | $63 | $71 |
| Category H: Matrix Digestion Surcharge | * | $68 | $91 | $102 |
Rates Effective July 1, 2022 through June 30, 2023
| Method | Cancer Center* Rate | UCSF Recharge | External Non-industry | External Industry |
|---|---|---|---|---|
| Category A: LC-MS/MS. Straightforward Sample Prep and Data Analysis: ex. Cotinine/3HC, or Anabasine/Anatabine, or NNN/NNK |
* | $108 | $144 | $216 |
| Category B: LC-MS/MS. Moderate Sample Prep/Data Analysis: ex. Bupropion and Bupropion Metabolites, or Caffeine and Caffeine Metabolites |
* | $125 | $166 | $249 |
| Category C: LC-MS/MS. Complex Sample Prep/Data Analysis: such as: NNAL; or PAH Metabolites; or Mercapturic acid metabolites; or Total Nicotine Equivalents |
* | $169 | $225 | $338 |
|
Category E:
GC-MS/MS, Triple Quadrupole MS: ex Low-Level Nicotine, or PAHs
|
* | $126 | $167 | $251 |
| Category F: GC: Nicotine/Cotinine |
* | $70 | $93 | $140 |
| Category G: Creatinine |
* | $43 | $57 | $86 |
| Category H: Matrix Digestion Surcharge |
* | $62 | $82 | $123 |
* The Cancer Center rate, available to official members for Cancer research projects ONLY, is calculated as 60 percent of the regular UCSF recharge rate, with the differential paid from Cancer Center funds. For proposals and budgeting, please use the UCSF recharge rate as there is an overall budget cap. (For reference, a list of Cancer Center members is available here.)
Note: Category D has been phased out due to lack of use.
Acknowledgment
Publications generated from use of this facility should appropriately acknowledge the UCSF Helen Diller Family Comprehensive Cancer Center Tobacco and Carcinogens Biomarkers Core.
Disclaimer
The UCSF Clinical Pharmacology Laboratory is a research facility and does not report patient specific results for the diagnosis, prevention or treatment of any disease or impairment of, or the assessment of the health of, individual patients. Results of analyses carried out by this laboratory may not be used for purposes of litigation and may not be used as evidence in a court of law.
Additional Resources
A searchable database of core facilities at all UCSF campus locations, provided by the Clinical and Translational Science Institute at UCSF, is available here.